Camilla Fröhlich
Publications by Year
Research Areas
HER2/EGFR in Cancer Research, Cell Adhesion Molecules Research, Monoclonal and Polyclonal Antibodies Research, Peptidase Inhibition and Analysis, Cancer Cells and Metastasis
Most-Cited Works
- → The Cysteine-Rich Domain of Human Adam 12 Supports Cell Adhesion through Syndecans and Triggers Signaling Events That Lead to β1 Integrin–Dependent Cell Spreading(2000)245 cited
- → A Role for ADAM12 in Breast Tumor Progression and Stromal Cell Apoptosis(2005)143 cited
- → Reduction of the Disintegrin and Metalloprotease ADAM12 in Preeclampsia(2005)128 cited
- → Molecular Profiling of ADAM12 in Human Bladder Cancer(2006)122 cited
- → ADAM12: a novel first‐trimester maternal serum marker for Down syndrome(2003)106 cited
- → CD4+ and CD8a+ PET imaging predicts response to novel PD-1 checkpoint inhibitor: studies of Sym021 in syngeneic mouse cancer models(2019)105 cited
- → ADAM12 redistributes and activates MMP-14, resulting in gelatin degradation, reduced apoptosis, and increased tumor growth(2013)72 cited
- → ADAM12 Alleviates the Skeletal Muscle Pathology in mdx Dystrophic Mice(2002)64 cited
- → ADAM12 is expressed in the tumour vasculature and mediates ectodomain shedding of several membrane-anchored endothelial proteins(2013)58 cited
- → ADAM12 Produced by Tumor Cells Rather than Stromal Cells Accelerates Breast Tumor Progression(2011)56 cited